Fatal Pneumonia Caused by Corynebacterium Group JK after Treatment of Staphylococcus aureus Pneumonia.
スポンサーリンク
概要
- 論文の詳細を見る
A 76-year-old man who was admitted to the hospital because of chronic renal insufficiency and chronic hepatitis died of Corynebacterium group JK pneumonia, after showing a slight improvement by treatment of Staphylococcus aureus with sulbactam/cefoperazone and minocycline. Transtracheal aspiration (TTA) just before his death revealed numerous gram-positive bacilli phagocytized by many neutrophils and more than 108 colony forming units (CFU)/ml of Corynebacterium group JK. A drug susceptibility test showed Corynebacterium group JK was resistant to many antibiotics, with the exception of vancomycin and amikacin.(Internal Medicine 31 : 930-932, 1992)
- 社団法人 日本内科学会の論文
著者
-
MAESAKI Shigefumi
The Second Department of Internal Medicine, Nagasaki University School of Medicine
-
Koga Hironobu
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Hara Kohei
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Miyazaki Yoshitsugu
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Kohno Shigeru
The Scientific Assembly For Infection And Tuberculosis Of The Japanese Respiratory Society
-
Higashiyama Yasuhito
The Second Department of Internal Medicine, Nagasaki University School of Medicine
-
SUGAHARA Kazuyuki
the Department of Clinical Laboratory, Nagasaki University Hospital
-
YAMADA Hiroshi
the Second Department of Internal Medicine, Nagasaki University School of Medicine
-
YOSHITOMI Yuko
the Second Department of Internal Medicine, Nagasaki University School of Medicine
-
MATSUDA Haruko
the Second Department of Internal Medicine, Nagasaki University School of Medicine
-
MITSUTAKE Kohtarou
the Second Department of Internal Medicine, Nagasaki University School of Medicine
-
KAKU Mitsuo
the Department of Clinical Laboratory, Nagasaki University Hospital
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Two Patients Who Developed Leptospirosis-Associated Acute Renal Failure within the Same Season
- Echocardiographic Evaluation of Right Cardiac Function in Patients with Chronic Pulmonary Diseases
- Two sporadic cases of infections due to Klebsiella pneumoniae resistant to expanded-spectrum cephalosporins in Japan
- Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan